Ling Wei
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 10%
- RNA modifications and cancer
- Circular RNAs in diseases
- Epigenetics and DNA Methylation
- RNA Research and Splicing
Papers in
-
- RNA modifications and cancer 9
- Circular RNAs in diseases 4
- Epigenetics and DNA Methylation 4
- Kruppel-like factors research 2
-
- Cancer-related molecular mechanisms research 12
- MicroRNA in disease regulation 3
- Cancer Genomics and Diagnostics 2
- Co-authors
- Nasha Zhang (4 shared papers)Ming Yang (4 shared papers)Liyan Lv (3 shared papers)Xingwu Wang (3 shared papers)Yan Zheng (2 shared papers)Jujie Sun (2 shared papers)Yeyang Xu (1 shared paper)Yue Shen (1 shared paper)
- Journals
- Nucleic Acids Research (2 papers)The International Journal of Biochemistry & Cell Biology (2 papers)Frontiers in Genetics (2 papers)Molecular Cancer (2 papers)Protein & Cell (1 paper)
- Partner nations
- ChinaUnited StatesRomania
In The Last Decade
Ling Wei
35 papers receiving 1.2k citations
Ling Wei's Hit Papers
Peers
Comparison fields: 5 of 81
- Cancer Research 627
- Molecular Biology 719
- Health, Toxicology and Mutagenesis 83
- Pulmonary and Respiratory Medicine 118
- Oncology 98
Countries citing papers authored by Ling Wei
This map shows the geographic impact of Ling Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Wei more than expected).
Fields of papers citing papers by Ling Wei
This network shows the impact of papers produced by Ling Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Wei. The network helps show where Ling Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Ling Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Noncoding RNAs in gastric cancer: implications for drug resistance Hit paper breakdown → | 2020 | 363 |
| 2 | 2019 | 251 | |
| 3 | 2020 | 82 | |
| 4 | 2016 | 81 | |
| 5 | 2015 | 76 | |
| 6 | 2019 | 74 | |
| 7 | 2006 | 34 | |
| 8 | 2017 | 30 | |
| 9 | 2015 | 25 | |
| 10 | 2014 | 24 | |
| 11 | 2022 | 23 | |
| 12 | 2021 | 19 | |
| 13 | 2008 | 19 | |
| 14 | 2017 | 18 | |
| 15 | 2023 | 15 | |
| 16 | 2021 | 13 | |
| 17 | 2018 | 11 | |
| 18 | 2020 | 11 | |
| 19 | 2021 | 10 | |
| 20 | 2017 | 9 |
About Ling Wei
Ling Wei is a scholar working on Molecular Biology, Cancer Research, Genetics, Oncology and Immunology, having authored 36 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (12 papers), RNA modifications and cancer (9 papers), Genetic Syndromes and Imprinting (5 papers), Circular RNAs in diseases (4 papers), Epigenetics and DNA Methylation (4 papers), MicroRNA in disease regulation (3 papers), Cancer Genomics and Diagnostics (2 papers) and Kruppel-like factors research (2 papers). The work is most often cited by research in Cancer Research (627 citations), Molecular Biology (719 citations), Health, Toxicology and Mutagenesis (83 citations), Pulmonary and Respiratory Medicine (118 citations) and Oncology (98 citations). Ling Wei has collaborated with scholars based in China, United States and Romania. Frequent co-authors include Nasha Zhang, Ming Yang, Liyan Lv, Xingwu Wang, Yan Zheng, Jujie Sun, Yeyang Xu, Yue Shen, Jiandong Liu and Huaixin Xing. Their work appears in journals such as Nucleic Acids Research, The International Journal of Biochemistry & Cell Biology, Frontiers in Genetics, Molecular Cancer and Protein & Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.